The Current Status of Psilocybin Research: Depression, Anxiety & Trauma
By Pam Conboy Part 3 (a. & b.) of this series will provide an overview of the current status of psilocybin research in a variety of conditions. Today’s article will focus on its efficacy in depression, anxiety, and trauma. Breakthrough Therapy (2018;2019) FDA Recognizes Psilocybin’s Therapeutic Potential in the Treatment of Depression As mentioned in […]
Self-Compassion Has Mental and Physical Benefits
Razi Berry A wonderful clinical tool is self-healing, and I have found that this is only possible when one learns self-kindness and compassion. I love to see new research that supports the physical changes that occur in the body during exercises that promote self-compassion and loving kindness. This week, such a study was published by […]
Reclassification Recommendations for Psilocybin From Schedule I to Schedule IV
Razi Berry If phase III clinical trials are successful, researchers suggest categorizing the drug as schedule IV In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule I drug—one with no […]